Skip to main content
. 2018 Aug 14;9:454. doi: 10.3389/fendo.2018.00454

Figure 3.

Figure 3

Main findings of subgroup analyses in the meta-analysis of randomized controlled trials assessing the effect of LT4 therapy on SBP in SCH patients.